Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Diagnostic Assessment and Classification of Toxidromes

Diagnostic Assessment and Classification of Toxidromes

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Learning Objective

Apply diagnostic and classification criteria to assess a patient with a suspected toxidrome and guide initial management.

1. Clinical Examination and Toxidrome Phenotyping

Rapid bedside phenotyping uses clusters of vital‐sign patterns, skin and mucosal findings, pupil exam, bowel sounds and neuromuscular signs to distinguish major toxidromes and trigger early targeted therapy.

Anticholinergic (e.g., antihistamines, TCAs, antipsychotics)

  • Delirium or agitation (“mad as a hatter”)
  • Mydriasis, dry mucosa, flushed skin (“red as a beet, dry as a bone”)
  • Tachycardia, urinary retention, decreased bowel sounds

Cholinergic (organophosphates, carbamates)

  • Muscarinic: SLUDGE (salivation, lacrimation, urination, defecation, GI cramps, emesis), bronchorrhea, bronchospasm, bradycardia
  • Nicotinic: Muscle fasciculations, weakness, paralysis, hypertension, tachycardia (early phase)

Sympathomimetic (cocaine, amphetamines)

  • Agitation, diaphoresis, hyperthermia
  • Mydriasis, hypertension, tachycardia

Opioid (morphine, fentanyl)

  • CNS & respiratory depression
  • Miosis (“pinpoint pupils”), hypotension

Sedative-hypnotic (benzodiazepines, barbiturates)

  • Somnolence, ataxia, hypotonia
  • Hypoventilation; pupils normal or mildly constricted

Serotonin Syndrome (SSRIs, MAOIs, tramadol, linezolid)

  • Neuromuscular: Inducible/spontaneous clonus, hyperreflexia, tremor
  • Autonomic: Fever, diaphoresis, tachycardia, hypertension
  • Rapid onset (hours)

Neuroleptic Malignant Syndrome (dopamine antagonists)

  • “Lead-pipe” rigidity, hyporeflexia
  • Fever, autonomic instability (BP swings, tachycardia)
  • Insidious onset over days
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Pearls
  • Dry skin vs diaphoresis is the single most reliable distinction between anticholinergic and sympathomimetic toxidromes.
  • A brief naloxone challenge (0.04 mg IV) can unmask opioid vs sedative-hypnotic depression.

2. Laboratory and Diagnostic Testing

Targeted labs confirm clinical phenotypes, quantify severity and direct antidote dosing. Timing and specimen handling are critical to avoid false negatives.

Key Laboratory and Diagnostic Tests in Toxicology
Test/Marker Clinical Significance Application & Monitoring
Serum Cholinesterase Butyrylcholinesterase ↓ ≥50% indicates severe organophosphate poisoning. Guides duration of atropine/pralidoxime dosing; high risk of respiratory failure.
Creatine Kinase (CK) Elevated (>1,000 U/L) in NMS and severe serotonin syndrome. Monitor for rhabdomyolysis and subsequent acute kidney injury.
ABG & Lactate Respiratory acidosis in sedative/opioid overdose. Anion-gap metabolic acidosis suggests toxic alcohols. Assess ventilation status and tissue perfusion. An osmolal gap is also key for toxic alcohols.
Quantitative Drug Levels Specific levels (e.g., acetaminophen, salicylate) are critical for prognosis. Use acetaminophen nomogram for N-acetylcysteine; guide alkalinization for salicylates.
Toxicology Screens Immunoassays are rapid but have limitations (false +/-). GC-MS is confirmatory. Useful for unexpected or novel agents; do not let results delay empiric therapy.
Imaging (CT/MRI) Generally low yield for toxidromes unless there are focal deficits or trauma. Reserve for specific indications; do not delay administration of antidotes.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Pearls
  • Serial butyrylcholinesterase every 6 hours optimizes pralidoxime infusion in organophosphate patients.
  • Always draw acetaminophen and salicylate levels at least 4 hours post‐ingestion to avoid misleading troughs.

3. Severity Scoring and Algorithmic Frameworks

Validated criteria and decision pathways improve risk stratification, ICU triage and resource allocation.

Hunter Serotonin Toxicity Criteria

Diagnosis requires exposure to a serotonergic agent plus one of the following:

  • Spontaneous clonus
  • Inducible clonus plus agitation or diaphoresis
  • Ocular clonus plus agitation or diaphoresis
  • Tremor plus hyperreflexia
  • Hypertonia plus temperature >38°C plus ocular or inducible clonus

This tool has high specificity (~97%) for serotonin syndrome.

QRS Duration Algorithm in TCA Overdose

An algorithmic approach based on the QRS duration on ECG is critical for managing potential cardiotoxicity from tricyclic antidepressant overdose.

TCA Overdose QRS Duration Algorithm A flowchart for managing TCA overdose based on QRS duration. QRS less than 100ms requires monitoring. QRS between 100-160ms requires sodium bicarbonate. QRS greater than 160ms requires advanced therapies like hypertonic saline or lipid emulsion. Suspected TCA Overdose Obtain 12-lead ECG Measure QRS Duration QRS ≤100 ms Low Risk Monitor with serial ECGs QRS 100-160 ms Moderate Risk Give Sodium Bicarbonate (1-2 mEq/kg bolus + infusion) QRS >160 ms High Risk for Arrhythmia Consider: – Hypertonic Saline – Lipid Emulsion – Advanced Cardiac Life Support
Figure 1: TCA Overdose Management Algorithm. This flowchart illustrates a risk-stratified approach to TCA cardiotoxicity based on QRS duration.

Other Frameworks

  • Mixed Toxidromes: Weighted scoring systems that assess autonomic, muscarinic, neuromuscular, and ECG findings can help identify the predominant phenotype when polypharmacy complicates the clinical picture.
  • ICU Admission Pathways: Standardized criteria for ICU admission include airway compromise, refractory hypotension, life-threatening arrhythmias, or severe hyperthermia. Early consultation with a poison control center or medical toxicologist is crucial.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Pearls
  • A standardized TCA QRS‐based protocol can reduce ventricular arrhythmias by approximately 40%.
  • In mixed presentations, benzodiazepines and active cooling measures are effective for addressing both sympathomimetic and anticholinergic hyperthermia and agitation.

4. Diagnostic Challenges and Pitfalls

Overlapping syndromes, altered exam conditions, and patient factors can obscure classic toxidrome patterns. It is essential to maintain a high index of suspicion.

Polypharmacy & Atypical Agents

Ingestion of multiple substances can create masked or confusing clinical phenotypes. Furthermore, patient tolerance to a substance may elevate the threshold dose required to produce classic signs.

Point‐of‐Care Testing Limitations

Standard urine drug screens are often immunoassays that can miss volatile agents (like toxic alcohols) and fail to detect novel psychoactive substances. Results should be interpreted with caution.

Sedated/Intubated Patients

A baseline neurologic impairment, sedation, or neuromuscular blockade precludes an accurate assessment of reflexes and clonus. Structured sedation vacations, when safe, can be invaluable for serial neurologic exams.

Pediatric Considerations

Children have unique physiology that alters toxidrome presentation. They have a lower baseline cholinesterase level, which can lead to false-low readings. Hypotension may be an early, rather than late, sign in anticholinergic poisoning. All antidote dosing and fluid resuscitation must be strictly weight-based.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Pearls
  • In intubated patients, passive stretching of the ankle or wrist can sometimes reveal inducible clonus even under moderate sedation.
  • Never delay empiric therapy (e.g., naloxone, bicarbonate, benzodiazepines) in high‐suspicion cases while awaiting confirmatory toxicology results.